David Devos obtained doctorial degrees in both neurology and neuroscience from the University of Lille, France. Between 2002 and 2010, he worked as a hospital physician in the Department of Neurology and Movement Disorders of the Centre Hospitalier Régional Universitaire de Lille. He is now a professor in medical pharmacology (Lille University, INSERM U1171). His main research interest is in developing new symptomatic and disease-modifying strategies in neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral sclerosis, dementia and cerebellar ataxia. His research is mainly based upon clinical trials but also includes preclinical, translational and other clinical studies in neuropsychopharmacology.